FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.59), $0.02 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $9.44 million versus the consensus estimate of $9.75 million.
Wave is entering 2021 with depth and diversity throughout our pipeline and platform, the result of focused and deliberate execution, and a steadfast commitment to leading a... More

